What is William Blair’s Estimate for CRSP Q2 Earnings?
CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) – Equities researchers at William Blair reduced their Q2 2025 EPS estimates for shares of CRISPR Therapeutics in a research note issued on Tuesday, May 20th. William Blair analyst S. Corwin now forecasts that the company will earn ($2.27) per share for the quarter, down from their prior […]
CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) – Equities researchers at William Blair reduced their Q2 2025 EPS estimates for shares of CRISPR Therapeutics in a research note issued on Tuesday, May 20th. William Blair analyst S. Corwin now forecasts that the company will earn ($2.27) per share for the quarter, down from their prior […]
